International comparison of glycaemic control in people with type 1 diabetes: an update and extension
Fecha
2022Language
en
Materia
Resumen
Aims: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes. Methods: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 population and five clinic-based data sources in countries or regions between 2016 and 2020. Median HbA1c(IQR) and proportions of individuals with HbA1c < 58 mmol/mol (<7.5%), 58–74 mmol/mol (7.5–8.9%) and ≥75 mmol/mol (≥9.0%) were compared between populations for individuals aged <15, 15–24 and ≥25 years. Logistic regression was used to estimate the odds ratio (OR) of HbA1c < 58 mmol/mol (<7.5%) relative to ≥58 mmol/mol (≥7.5%), stratified and adjusted for sex, age and data source. Where possible, changes in the proportion of individuals in each HbA1c category compared to previous estimates were calculated. Results: Median HbA1c varied from 55 to 79 mmol/mol (7.2 to 9.4%) across data sources and age groups so a pooled estimate was deemed inappropriate. OR (95% CI) for HbA1c< 58 mmol/mol (<7.5%) were 0.91 (0.90–0.92) for women compared to men, 1.68 (1.65–1.71) for people aged <15 years and 0.81 (0.79–0.82) aged15–24 years compared to those aged ≥25 years. Differences between populations persisted after adjusting for sex, age and data source. In general, compared to our previous analysis, the proportion of people with an HbA1c < 58 mmol/l (<7.5%) increased and proportions of people with HbA1c≥ 75 mmol/mol (≥9.0%) decreased. Conclusions: Glycaemic control of type 1 diabetes continues to vary substantially between age groups and data sources. While some improvement over time has been observed, glycaemic control remains sub-optimal for most people with Type 1 diabetes. © 2021 Diabetes UK.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Quality of life in subjects with type 2 diabetes mellitus with diabetic retinopathy: A case–control study
Ligda G., Ploubidis D., Foteli S., Kontou P.I., Nikolaou C., Tentolouris N. (2019)Aims: Diabetic retinopathy (DR) as a common complication of Type 2 Diabetes Mellitus (T2DM) affecting negatively quality of life (QoL). Assessing of QoL in patients with DR is a prerequisite for the evaluation of their ... -
SLC2A1 Tag SNPs in Greek Patients with Diabetic Retinopathy and Nephropathy
Siokas V., Fotiadou A., Dardiotis E., Kotoula M.G., Tachmitzi S.V., Chatzoulis D.Z., Zintzaras E., Stefanidis I., Tsironi E.E. (2019)Backround: Genetic variants are implicated in the development of diabetic retinopathy (DR) and nephropathy (DN). The role of solute carrier family 2-facilitated glucose transporter member 1 (SLC2A1), also known as glucose ... -
The contribution of genetic variants of SLC2A1 gene in t2dm and T2DM-nephropathy: Association study and meta-analysis
Stefanidis I., Tziastoudi M., Tsironi E.E., Dardiotis E., Tachmitzi S.V., Fotiadou A., Pissas G., Kytoudis K., Sounidaki M., Ampatzis G., Mertens P.R., Liakopoulos V., Eleftheriadis T., Hadjigeorgiou G.M., Santos M., Zintzaras E. (2018)An association study was conducted to investigate the relation between 14 variants of glucose transporter 1 gene (SLC2A1) and the risk of type 2 diabetes (T2DM) leading to nephropathy. We also performed a meta-analysis of ...